Literature DB >> 25341724

Risk of fracture in urolithiasis: a population-based cohort study using the health improvement network.

Michelle R Denburg1, Mary B Leonard2, Kevin Haynes3, Shamir Tuchman4, Gregory Tasian2, Justine Shults2, Lawrence Copelovitch2.   

Abstract

BACKGROUND AND OBJECTIVES: Studies have shown decreased bone mineral density in individuals with urolithiasis, but their burden of fracture remains unclear. This study sought to determine whether urolithiasis is associated with increased fracture risk across the lifespan and to delineate sex effects. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A population-based retrospective cohort study using The Health Improvement Network was performed. The median calendar year for the start of the observation period was 2004 (1994-2012). This study identified 51,785 participants with ≥1 of 87 diagnostic codes for urolithiasis and 517,267 randomly selected age-, sex-, and practice-matched participants. Cox regression was used to estimate the hazard ratio (HR) for first fracture. Fractures identified using diagnostic codes were classified by anatomic site.
RESULTS: Median age was 53 years, and 67% of participants were men, confirming their greater urolithiasis burden. Median time from urolithiasis diagnosis to fracture was 10 years. The HR for fracture associated with urolithiasis differed by sex and age (P for interactions, P≤0.003). In men, the adjusted HR was greatest in adolescence (1.55; 95% confidence interval [95% CI], 1.07 to 2.25) with an overall HR of 1.10 (95% CI, 1.05 to 1.16). Urolithiasis was associated with higher fracture risk in women aged 30-79 years (HR, 1.17-1.52), and was highest in women aged 30-39 years (HR, 1.52; 95% CI, 1.23 to 1.87). Peak background fracture rates were highest in boys aged 10-19 years and in women aged 70-79 years. The incidence per 10,000 person-years in participants with versus without urolithiasis was 392 versus 258 in male participants aged 10-19 years, and 263 versus 218 in women aged 70-79 years. Distribution of fracture site within sex did not differ between participants with versus without urolithiasis.
CONCLUSIONS: Urolithiasis was associated with higher incident fracture risk. The significantly higher risk at times of peak background fracture incidence in adolescent boys and elderly women has profound public health implications.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Keywords:  epidemiology and outcomes; kidney stones; risk factors

Mesh:

Year:  2014        PMID: 25341724      PMCID: PMC4255404          DOI: 10.2215/CJN.04340514

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  38 in total

1.  Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial.

Authors:  I R Reid; R W Ames; B J Orr-Walker; J M Clearwater; A M Horne; M C Evans; M A Murray; A R McNeil; G D Gamble
Journal:  Am J Med       Date:  2000-10-01       Impact factor: 4.965

2.  Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis.

Authors:  John R Asplin; Kimberly A Bauer; Jennifer Kinder; Georg Müller; Brian J Coe; Joan H Parks; Fredric L Coe
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

3.  Time trends in reported prevalence of kidney stones in the United States: 1976-1994.

Authors:  Kiriaki K Stamatelou; Mildred E Francis; Camille A Jones; Leroy M Nyberg; Gary C Curhan
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

4.  Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial.

Authors:  A Z LaCroix; S M Ott; L Ichikawa; D Scholes; W E Barlow
Journal:  Ann Intern Med       Date:  2000-10-03       Impact factor: 25.391

5.  Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey.

Authors:  D S Lauderdale; R A Thisted; M Wen; M J Favus
Journal:  J Bone Miner Res       Date:  2001-10       Impact factor: 6.741

6.  Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis.

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França; Marcelo Ferraz Oliveira Souto
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

7.  Ethnic variation in bone density in premenopausal and early perimenopausal women: effects of anthropometric and lifestyle factors.

Authors:  Joel S Finkelstein; Mei-Ling T Lee; MaryFran Sowers; Bruce Ettinger; Robert M Neer; Jennifer L Kelsey; Jane A Cauley; Mei-Hua Huang; Gail A Greendale
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

8.  Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis.

Authors:  Sandro Giannini; Martino Nobile; Luca Dalle Carbonare; Maria Giuseppina Lodetti; Stefania Sella; Gabriele Vittadello; Nadia Minicuci; Gaetano Crepaldi
Journal:  Eur J Endocrinol       Date:  2003-09       Impact factor: 6.664

9.  Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women.

Authors:  Cara Tannenbaum; Julie Clark; Kevin Schwartzman; Sylvan Wallenstein; Robert Lapinski; Diane Meier; Marjorie Luckey
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

10.  Diuretic initiation and the acute risk of hip fracture.

Authors:  S D Berry; Y Zhu; H Choi; D P Kiel; Y Zhang
Journal:  Osteoporos Int       Date:  2012-07-13       Impact factor: 4.507

View more
  32 in total

1.  Stones: Bone health in patients with kidney stones.

Authors:  Miguel Angel Arrabal-Polo; Miguel Arrabal-Martin
Journal:  Nat Rev Urol       Date:  2014-12-09       Impact factor: 14.432

2.  Stones, bones, and cardiovascular groans.

Authors:  Eric N Taylor
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-29       Impact factor: 8.237

3.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

4.  Urinary Tract Stones and Osteoporosis: Findings From the Women's Health Initiative.

Authors:  Laura D Carbone; Kathleen M Hovey; Christopher A Andrews; Fridtjof Thomas; Mathew D Sorensen; Carolyn J Crandall; Nelson B Watts; Monique Bethel; Karen C Johnson
Journal:  J Bone Miner Res       Date:  2015-07-14       Impact factor: 6.741

5.  Relationship between Urinary Calcium and Bone Mineral Density in Patients with Calcium Nephrolithiasis.

Authors:  Khashayar Sakhaee; Naim M Maalouf; John Poindexter; Beverley Adams-Huet; Orson W Moe
Journal:  J Urol       Date:  2017-01-05       Impact factor: 7.450

6.  Urinary stone disease in pediatric and adult metabolic bone clinic patients.

Authors:  Andrew L Schwaderer; Abimbola Oduguwa; Kirsten Kusumi
Journal:  Urolithiasis       Date:  2017-03-08       Impact factor: 3.436

7.  Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

Authors:  Carmen Inés Rodriguez Cuellar; Peter Zhan Tao Wang; Michael Freundlich; Guido Filler
Journal:  Pediatr Nephrol       Date:  2019-01-04       Impact factor: 3.714

8.  Stone formation in patients less than 20 years of age is associated with higher rates of stone recurrence: Results from the Registry for Stones of the Kidney and Ureter (ReSKU).

Authors:  Yi Li; David Bayne; Scott Wiener; Justin Ahn; Marshall Stoller; Thomas Chi
Journal:  J Pediatr Urol       Date:  2020-03-25       Impact factor: 1.830

9.  Kidney Stone Recurrence among Children and Adolescents.

Authors:  Gregory E Tasian; Abdo E Kabarriti; Angela Kalmus; Susan L Furth
Journal:  J Urol       Date:  2016-08-10       Impact factor: 7.450

Review 10.  Insights Into Nephrolithiasis From the Nurses' Health Studies.

Authors:  Megan L Prochaska; Eric N Taylor; Gary C Curhan
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.